ASELIZUMAB
UNII 8Y539D78FU

Substance Identification & Data

This profile provides standardized clinical and technical data for Aselizumab, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 8Y539D78FU.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 395639-53-9 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code
8Y539D78FU
CAS Registry Number
395639-53-9
RxNorm Concept ID
N/A

Detailed Substance Profile

Preferred Name
ASELIZUMAB
Official standardized name for this substance within the FDA UNII nomenclature system.
NCI Thesaurus
C171823
National Cancer Institute reference terminology for clinical and research data.
INN ID
8291
Sequential identifier assigned via the WHO International Nonproprietary Name program.
Substance Type
protein
ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Aselizumab. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

ASELIZUMAB

Common Names & Synonyms

ASELIZUMAB [INN]
IMMUNOGLOBULIN G4, ANTI-(L-SELECTIN) (HUMAN-MOUSE MONOCLONAL HUDREG-55 HEAVY CHAIN), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL HUDREG-55 LIGHT CHAIN, DIMER

External Clinical & Regulatory Resources

CAS
Common Chemistry
NCATS
Inxight Drugs
NLM
DailyMed Products
NCATS
GSRS Full Record
NIH
NCI Thesaurus